Startups
CellSpring develops blood-based tests for diagnosing early stage cancer. The tests rely on a proprietary exosomal biomarker discovery technology developed at world class research institutes in Switzerland.
Detecting cancer early means catching it before a patient even has symptoms -- when the full gamut of therapeutic options is available and most likely to succeed.
Detecting cancer early means catching it before a patient even has symptoms -- when the full gamut of therapeutic options is available and most likely to succeed.
Overview
Location
Switzerland, Zurich
Employees
1-10
Total raised
$81.08K
Founded date
2015
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| MassChallenge | masschallenge.org |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 20
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 31, 2019 | MassChallenge Switzerland Awards CHF 500k to 12 Top Startups in its 2019 Cohort | Renens, November 1, 2019 – MassChallenge Switzerland, part of MassChallenge’s global network of zero-equity startup accelerators, yesterday awarded CHF 500K in cash prizes to the 12 top startups in its fourth cohort. “I would like to congr... |
| Oct 11, 2019 | MassChallenge reveals the 2019 finalists | |
| Oct 10, 2019 | MassChallenge Switzerland Announces 2019’s 12 Top Finalists | Renens, October 10, 2019 – MassChallenge Switzerland, part of MassChallenge’s global network of zero-equity startup accelerators, today announced the top 12 Finalists from the 2019 program. These startups will now will compete for the cash ... |
| May 17, 2019 | Here is the 4th MassChallenge Switzerland Cohort | Normal 0 21 false false false FR-CH X-NONE X-NONE |
| Sep 18, 2017 | BaseLaunch startups: From gene therapies to digital measurement | |
| Jan 31, 2017 | Two venture kickers selected among Forbes “30under30” Europe 2017 | The 2013 Venture Kick startup DEPsys raised 3 million in Series A in 2016 to further develop GridEye, a network optimization platform which measures, monitors and controls the low-voltage grid for an efficient integration of renewable energ... |
| Jan 18, 2017 | Nine Swiss change makers among the Forbes “30under30” Europe | |
| Sep 26, 2016 | CellSpring collaborates with Plasticell | |
| Jun 13, 2016 | Wie Startups von einer Zusammenarbeit mit Designern profitieren |
Show more
Reviews 0
FAQ about CellSpring
When was CellSpring founded?
CellSpring was founded in 2015.
How much funding has CellSpring raised?
CellSpring has raised $81.08K in total across 1 funding round.
Who has invested in CellSpring?
Parsers VC lists 2 investors of CellSpring, among them MassChallenge.
What has the press written about CellSpring?
Parsers VC has collected 20 articles mentioning CellSpring, among them “MassChallenge Switzerland Awards CHF 500k to 12 Top Startups in its 2019 Cohort” (Oct 31, 2019) and “MassChallenge reveals the 2019 finalists” (Oct 11, 2019).
Is CellSpring still active?
Yes, CellSpring is active; its latest activity on Parsers VC dates from Nov 1, 2019.